<![CDATA[Novo Nordisk A/S - Press Releases]]><![CDATA[Novo Nordisk receives FDA approval for Norditropin® FlexPro® for growth hormone treatment]]><![CDATA[Minister presents scholarships to young research talents]]><![CDATA[Novo Nordisk starts phase 1 trial with long-acting oral GLP-1 analogue]]><![CDATA[Novo Nordisk and Combine in research collaboration for the treatment of autoimmune diseases]]><![CDATA[Novo Nordisk licenses IL-21 mAb and patent rights to IL-21 antibodies from ZymoGenetics]]><![CDATA[Novo Nordisk starts phase 1 trial with oral insulin analogue]]><![CDATA[EFSD/Novo Nordisk partnership for diabetes research in Europe]]><![CDATA[Novo Nordisk extends programme of free insulin and diabetes care to reach 700 children in Bangladesh]]><![CDATA[New study results show that patients have higher treatment satisfaction with liraglutide compared to exenatide]]><![CDATA[The 4-T study of intensified insulin regimens shows excellent three-year glucose control with low risk of hypoglycaemia in type 2 diabetes]]><![CDATA[New data shows that type 2 diabetes patients who start insulin therapy with once-daily NovoMix® 30 achieve significantly greater HbA1c reduction than with insulin glargine. 1]]><![CDATA[New data shows that patients with type 2 diabetes improve their blood sugar control when switched to Victoza® from Byetta®]]><![CDATA[Novo Nordisk opens new research centre in Seattle]]><![CDATA[Novo Nordisk reaches settlement with the Danish authorities regarding Oil-for-Food activities]]><![CDATA[The Lancet publishes direct comparison study between liraglutide and exenatide]]><![CDATA[Two-year data show investigational drug liraglutide more effective at lowering blood sugar than glimepiride]]><![CDATA[New study first ever to directly compare once-daily Levemir® with another basal insulin analogue]]><![CDATA[New study directly comparing insulin delivery devices shows that Next Generation FlexPen® has a significantly lower injection force than SoloStar® and KwikPen®]]><![CDATA[Novo Nordisk reaches settlements with the US Securities and Exchange Commission and Department of Justice regarding Oil-for-Food activities]]><![CDATA[Novo Nordisk and VLST Corporation announce collaboration agreement]]>